Lista de obras -

Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update

artículo científico publicado en 2016

Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.

artículo científico publicado en 2008

Anaplastic Thyroid Cancer Cells Induce the Release of Mitochondrial Extracellular DNA Traps by Viable Neutrophils

scientific article published on 20 January 2020

Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer

artículo científico publicado en 2016

Associations between Systemic Sclerosis and Thyroid Diseases

artículo científico publicado en 2017

Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection

artículo científico publicado en 2014

Autoimmune thyroid disorders

artículo científico publicado en 2014

Breg Cells in Celiac Disease Isolated or Associated to Hashimoto's Thyroiditis

artículo científico publicado en 2018

CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.

artículo científico publicado en 2015

COVID-19 in Italian patients with rheumatic autoimmune systemic diseases

scientific article published on 14 October 2020

CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers

article

CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis.

artículo científico publicado en 2009

CXCL10 in psoriasis

artículo científico

CXCR3, CXCL10 and type 1 diabetes

artículo científico publicado en 2014

CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes

artículo científico

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases

artículo científico publicado en 2013

Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinaemia are associated with circulating levels of IFN-gamma and TNF-alpha

artículo científico publicado el 1 de noviembre de 2012

Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations

artículo científico publicado en 2015

Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis.

artículo científico

Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis.

artículo científico publicado en 2011

Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis

artículo científico publicado en 2007

Cytokines and HCV-related autoimmune disorders

artículo científico publicado en 2014

Cytokines and HCV-related disorders

artículo científico publicado en 2012

DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review

artículo científico publicado en 2023

Dedifferentiated thyroid cancer: a therapeutic challenge

artículo científico publicado en 2008

Endocrine manifestations of hepatitis C virus infection.

artículo científico publicado en 2009

Environmental Issues in Thyroid Diseases

artículo científico publicado en 2017

Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study

scientific article published on 04 December 2020

Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ.

artículo científico publicado en 2014

Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience

artículo científico publicado en 2017

Hepatitis C virus infection: evidence for an association with type 2 diabetes

artículo científico publicado en 2005

High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia

artículo científico publicado en 2009

High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia

artículo científico publicado en 2010

High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia

artículo científico publicado en 2009

High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10.

artículo científico publicado en 2011

High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ

artículo científico publicado en 2011

High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection

artículo científico publicado en 2008

High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis

artículo científico publicado en 2008

Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?

scientific article published on 08 August 2019

Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.

artículo científico publicado en 2008

Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up

artículo científico publicado en 2016

Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up

artículo científico publicado en 2013

Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10.

artículo científico publicado en 2013

Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis.

artículo científico publicado en 2015

Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: Modulation by peroxisome proliferator-activated receptor γ agonists

artículo científico publicado en 2012

Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis.

artículo científico publicado en 2010

Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines

artículo científico publicado en 2014

Molecular Targeted Therapies of Aggressive Thyroid Cancer

artículo científico publicado en 2015

N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C.

artículo científico publicado en 2010

New targeted molecular therapies for dedifferentiated thyroid cancer

artículo científico publicado en 2010

New therapies for dedifferentiated papillary thyroid cancer

artículo científico publicado en 2015

Novel Therapies for Thyroid Autoimmune Diseases.

artículo científico publicado en 2016

Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies

artículo científico publicado en 2020

Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study

scientific article published on 03 October 2018

Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2.

artículo científico publicado en 2013

Peroxisome Proliferator-Activated Receptor- γ in Thyroid Autoimmunity

artículo científico publicado en 2015

Prevalence of hypothyroidism and Graves disease in sarcoidosis

artículo científico publicado en 2006

Prevalence of thyroid dysfunctions in systemic lupus erythematosus

artículo científico publicado en 2009

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity

artículo científico publicado en 2017

Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer

artículo científico

RET TKI: potential role in thyroid cancers.

artículo científico publicado en 2012

Role of CXCL10 in cryoglobulinemia

artículo científico

Selective use of vandetanib in the treatment of thyroid cancer

artículo científico

Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection

artículo científico publicado en 2009

Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia

artículo científico publicado en 2009

Sorafenib and Thyroid Cancer ⬇️

artículo científico publicado el 1 de diciembre de 2013

Systemic Lupus Erythematosus and Thyroid Autoimmunity

artículo científico publicado en 2017

Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.

artículo científico publicado en 2012

Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity

artículo científico publicado en 2014

Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis

scientific article published on 15 August 2008

The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition

artículo científico publicado en 2019

The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients

artículo científico publicado en 2016

The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha.

artículo científico publicado en 2011

The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders

artículo científico publicado en 2016

The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.

artículo científico publicado en 2016

Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia

artículo científico publicado en 2017

Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study

artículo científico publicado en 2007

Thyroid disorders in chronic hepatitis C virus infection

artículo científico publicado en 2006

Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia

artículo científico

[Extrahepatic manifestations of hepatitis C virus: the thyroid disorders]

artículo científico publicado en 2005

Lista de obras de

Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update

Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.

Anaplastic Thyroid Cancer Cells Induce the Release of Mitochondrial Extracellular DNA Traps by Viable Neutrophils

Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer

Associations between Systemic Sclerosis and Thyroid Diseases

Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection

Autoimmune thyroid disorders

Breg Cells in Celiac Disease Isolated or Associated to Hashimoto's Thyroiditis

CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.

COVID-19 in Italian patients with rheumatic autoimmune systemic diseases

CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers

CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis.

CXCL10 in psoriasis

CXCR3, CXCL10 and type 1 diabetes

CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases

Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinaemia are associated with circulating levels of IFN-gamma and TNF-alpha

Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations

Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis.

Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis.

Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis

Cytokines and HCV-related autoimmune disorders

Cytokines and HCV-related disorders

DICER1 Syndrome: A Multicenter Surgical Experience and Systematic Review

Dedifferentiated thyroid cancer: a therapeutic challenge

Endocrine manifestations of hepatitis C virus infection.

Environmental Issues in Thyroid Diseases

Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study

Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ.

Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience

Hepatitis C virus infection: evidence for an association with type 2 diabetes

High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia

High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia

High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia

High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10.

High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ

High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection

High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis

Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?

Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.

Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up

Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up

Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10.

Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis.

Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: Modulation by peroxisome proliferator-activated receptor γ agonists

Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis.

Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines

Molecular Targeted Therapies of Aggressive Thyroid Cancer

N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C.

New targeted molecular therapies for dedifferentiated thyroid cancer

New therapies for dedifferentiated papillary thyroid cancer

Novel Therapies for Thyroid Autoimmune Diseases.

Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies

Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study

Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2.

Peroxisome Proliferator-Activated Receptor- γ in Thyroid Autoimmunity

Prevalence of hypothyroidism and Graves disease in sarcoidosis

Prevalence of thyroid dysfunctions in systemic lupus erythematosus

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity

Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer

RET TKI: potential role in thyroid cancers.

Role of CXCL10 in cryoglobulinemia

Selective use of vandetanib in the treatment of thyroid cancer

Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection

Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia

Sorafenib and Thyroid Cancer ⬇️

Systemic Lupus Erythematosus and Thyroid Autoimmunity

Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.

Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity

Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis

The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition

The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients

The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha.

The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders

The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.

Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia

Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study

Thyroid disorders in chronic hepatitis C virus infection

Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia